Research output per year
Research output per year
Personal profile
Research interests
Reasearch focus on adoptive T-cell therapy of cancer leading projects on CAR T-cell therapy of CD19+ malignancies and the feasibility of tumour infiltrating lymphocyte (TIL) therapy for brain cancer
Supervision of students carrying out projects on CAR T-cell therapy of solid malignancies, unraveling CAR signal transduction mechanisms and the application of TIL therapy for breast, ovarian and upper GI tumours.
Overview
Postdoctoral researcher withing the Clinical and Experimental Immunotherapy Group, Division of Cancer Sciences, based at the Manchester Cancer Research Centre Building.
Reasearch focus on adoptive T-cell therapy of cancer
Memberships of committees and professional bodies
European Association for Cancer Research member and ambassador
American Society of Gene and Cell Therapy member
Qualifications
DPhil - University of Oxford
MBioch - University of Oxford
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Beacons, Institutes and Platforms
- Cancer
- Manchester Cancer Research Centre
Keywords
- CAR T cells
- Immunotherapy
- TILs
Fingerprint
Dive into the research topics where Gray Kueberuwa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical feasibility and treatment outcomes with nonselected autologous tumor-infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma
Pillai, M., Jiang, Y., Lorigan, P. C., Thistlethwaite, F. C., Thomas, M., Kirillova, N., Bridgeman, J. S., Kueberuwa, G., Biswas, S., Velazquez, P., Chonzi, D., Guest, R. D., Roberts, Z. J. & Hawkins, R. E., 2022, In: American journal of cancer research. 12, 8, p. 3967-3984 18 p.Research output: Contribution to journal › Article › peer-review
-
Clinical Feasibility and Treatment Outcomes with Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients with Advanced Cutaneous Melanoma.
Hawkins, R. E., Jiang, Y., Lorigan, P. C., Thistlethwaite, F. C., Pillai, M., Thomas, M., Kirilova, N., Bridgeman, J. S., Kueberuwa, G., Guest, R. S. & Roberts, Z. J., Jul 2021, In: Cancer Research. 81, 13Research output: Contribution to journal › Meeting Abstract › peer-review
-
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Kueberuwa, G., Zheng, W., Kalaitsidou, M., Gilham, D. & Hawkins, R., 2018, In: Journal of Visualized Experiments. 140Research output: Contribution to journal › Article › peer-review
Open Access -
CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo
Kueberuwa, G., Gornall, H., Alcantar Orozco, E. M., Bouvier, D., Kapacee, Z. A., Hawkins, R. & Gilham, D., Dec 2017, In: Journal for ImmunoTherapy of Cancer. 5, 14Research output: Contribution to journal › Article › peer-review
Open Access -
CD19 CAR T-cells expressing IL-12 eradicate lymphoma in fully lymphoreplete mice through induction of host immunity
Kueberuwa, G., Kalaitsidou, M., Cheadle, E., Hawkins, R. & Gilham, D., 2017, In: Molecular therapy oncolytics.Research output: Contribution to journal › Article › peer-review
Open Access
Prizes
-
Miltenyi Young Investigator Award
Kueberuwa, Gray (Recipient), 16 May 2016
Prize: Prize (including medals and awards)
Activities
-
American Society of Gene & Cell Therapy (External organisation)
Gray Kueberuwa (Academic expert member)
19 Dec 2017 → 19 Dec 2018Activity: Membership › Membership of professional association
-
The University of Nottingham
Gray Kueberuwa (Secondee)
27 Nov 2017Activity: External visiting positions or secondments › Visiting an external academic institution
-
Preceptorship in Immunotherapy in Renal Cell Carcinoma
Gray Kueberuwa (Discussant)
14 Nov 2017 → 15 Nov 2017Activity: Talk or presentation › Invited talk
-
european association for cancer research (External organisation)
Gray Kueberuwa (Academic expert member)
1 Sep 2017 → 1 Sep 2018Activity: Membership › Membership of professional association
-
Euroscicon (External organisation)
Gray Kueberuwa (Academic expert member)
1 Dec 2016 → …Activity: Membership › Membership of committee
Press/Media
-
-
Friends of Rosie grant a further £66,500 following promising childhood brain tumour study
26/01/18
1 Media contribution
Press/Media: Blogs and social media
-